Innovent Biologics Announces FDA Approval of Pemazyre™ (Pemigatinib) as First Targeted Treatment for Adults with Previously Treated, Unresectable Locally Advanced or Metastatic Cholangiocarcinoma April 20, 2020
TraceLink Announces $1 Million Charitable Funding for COVID-19 Relief, Issues Call for Grant Proposals April 16, 2020
Precision Biosciences Appoints Dora Alvarado as Senior Vice President of Human Resources April 15, 2020
Precision BioSciences Announces Dosing of First Patient in Phase 1/2a Clinical Trial of PBCAR20A for Relapsed/Refractory NHL, CLL, and SLL April 7, 2020
Beam Therapeutics Licenses SIRION Biotech’s LentiBOOST™ Technology for its CAR-T pipeline April 7, 2020